Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 200 Results

Title
Intervention Indication Therapeutic Area Year Actions
Tislelizumab in combination with Paclitaxel, Cisplatin, and Radiotherapy for Oesophageal cancer Cisplatin (Platinol) , Paclitaxel (Taxol; paclitaxel albumin) , Tislelizumab (BGB-A317; BGBA-317) Squamous cell carcinoma (SCC) Head and Neck Cancer 2022 View  |  Download
Tislelizumab with chemotherapy for previously untreated unresectable or metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma Chemotherapy , Tislelizumab (BGB-A317; BGBA-317) Gastric cancer , Gastro-oesophageal junction adenocarcinoma Gastrointestinal Cancer 2022 View  |  Download
Tislelizumab with chemotherapy for previously
untreated advanced oesophageal squamous cell
carcinoma
Tislelizumab (BGB-A317; BGBA-317) Oesophageal squamous cell carcinoma Gastrointestinal Cancer 2022 View  |  Download
Tislelizumab with etoposide and carboplatin or cisplatin for treating small-cell lung cancer Carboplatin (Paraplatin) , Cisplatin (Platinol) , Etoposide , Tislelizumab (BGB-A317; BGBA-317) Small-cell lung cancer (SCLC) Lung and Respiratory Cancer 2022 View  |  Download
Trastuzumab deruxtecan for treating HER2-low, HR-positive, metastatic breast cancer Trastuzumab deruxtecan (DS-8201a; Enhertu) Breast cancer Breast Cancer 2022 View  |  Download
Treprostinil diethanolamine for treating pulmonary arterial hypertension Treprostinil diethanolamine Paroxysmal nocturnal haemoglobinuria Cardiovascular System , Respiratory System 2022 View  |  Download
Tucatinib with trastuzumab emtansine for treating unresectable, locally advanced or metastatic HER2 positive breast cancer Trastuzumab Emtansine (Kadcyla; T-DM1; PRO132365) , Tucatinib (ONT-380) Breast cancer Breast Cancer 2022 View  |  Download
Tucatinib with trastuzumab for treating colorectal cancer Trastuzumab (Herceptin; RG-597) , Tucatinib (ONT-380) Colorectal cancer Gastrointestinal Cancer 2022 View  |  Download
Ublituximab for treating multiple sclerosis Ublituximab (TG-1101; LFB-R603) Multiple sclerosis (MS) Neurology 2022 View  |  Download
Ustekinumab biosimilar for Plaque psoriasis Ustekinumab biosimilar (ONS3040; FYB202; CT-P43; BAT2206; DMB-3115; SB17; Bmab 1200; AVT04; ABP654) Plaque psoriasis Dermatology 2022 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications